1,012 results on '"Peschel C"'
Search Results
2. Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
3. Maligne Lymphome des Gastrointestinaltrakts
4. Immuntherapie
5. Maligne Lymphome — Morbus Hodgkin und Non-Hodgkin-Lymphome
6. Immun- und Gentherapie bei malignen Erkrankungen
7. Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
8. Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
9. Magenlymphome/gastrointestinale Stromatumoren des Magens (GIST, Magensarkom)
10. Maligne Lymphome — Morbus Hodgkin und Non-Hodgkin-Lymphome
11. Immun- und Gentherapie bei malignen Erkrankungen
12. Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
13. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
14. Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors
15. Grb10 is involved in BCR-ABL-positive leukemia in mice
16. Chronische myeloische Leukämie (CML)
17. Chronische myeloische Leukämie (CML)
18. Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients
19. 233P Breast cancer organoids mimic disease heterogeneity, allow high-throughput drug screening and show correlation with clinical response
20. Breast cancer organoids mimic disease heterogeneity, allow high-throughput drug screening and show correlation with clinical response
21. Role of Cytokines in the Regulation of Malignant B Cell Proliferation
22. Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model
23. Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells
24. Characterization and Assessment of CD26++ T Cells in the course of Haploidentical Stem Cell Transplantation: AB27
25. Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
26. The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care — an observational analysis on non-small-cell lung cancer patients
27. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
28. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1
29. The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro
30. Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer: Results of a phase II study in elderly patients or patients with impaired performance status
31. Recruitment of PKC-βII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70
32. The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells
33. Effektivität der intraperitonealen Immuntherapie mit dem trifunktionalen Antikörper Catumaxomab (anti-EpCAM x anti-CD3) bei Patienten mit gastrointestinalen Karzinomen: Ergebnisse einer matched-pair Analyse
34. Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
35. The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib
36. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL
37. Intraperitoneale Immuntherapie der Peritonealkarzinose gastrointestinaler Karzinome mit dem trifunktionalen Antikörper Catumaxomab (anti-EpCAM x anti-CD3): Eine Phase I/II Studie
38. Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib
39. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells
40. Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells
41. The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib
42. Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo
43. Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back
44. JAK1/2 inhibition leads to reduction of proinflammatory cytokines and promotion of regulatory T-cells in an allogeneic setting: O162
45. Murine stromal cells producing hyper-interleukin-6 and Flt3 ligand support expansion of early human hematopoietic progenitor cells without need of exogenous growth factors
46. Effects of imatinib on bone marrow engraftment in syngeneic mice
47. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27
48. Induction of a T helper cell response against the tumor-associated antigen HER2 using monocyte-derived dendritic cells
49. Gen-Immuntherapie zur Gen-Immuntherapie zur Behandlung von Malignomen Behandlung von Malignomen
50. Klinische Tumorsuppressor-Gentherapie bei Patienten mit malignen Tumoren
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.